Senior insider sale
Chief Financial Officer at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$2.15M
50.31K shares
What this filing means
ZANTE GREG plans to sell 50.31K shares of VIKING THERAPEUTICS, INC. valued at approximately $2.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/6/2025ACC: 0001950047-25-000164
Officer· Chief Financial Officer
Since Jan 2021
50.31K
Shares to sell
$2.15M
Approx. market value
50.31K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Performance Stock Units
Not Applicable
1/4/2025
11.72KRestricted stock vesting under a registered plan
Not Applicable
1/3/2024
12.62KRestricted stock vesting under a registered plan
Not Applicable
1/3/2023
16.35KRestricted stock vesting under a registered plan
Not Applicable
1/3/2022
9.62KTotal acquired50.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2025 | Performance Stock Units Not Applicable | 11.72K | — |
1/3/2024 | Restricted stock vesting under a registered plan Not Applicable | 12.62K | — |
1/3/2023 | Restricted stock vesting under a registered plan Not Applicable | 16.35K | — |
1/3/2022 | Restricted stock vesting under a registered plan Not Applicable | 9.62K | — |
| Total | 50.31K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
50.31K
Market value
$2.15M
1/6/2025
Total
Units
50.31K
Value
$2.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/6/2025 | 50.31K | $2.15M | NASDAQ | Planned |
| Total | 50.31K | $2.15M | ||